Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Respiratory Investigation|August 10, 2024
Molecular analysis of non-small cell lung cancer using a dual-targeted DNA and RNA comprehensive genomic profiling panelHidenori Kage, Shinji Kohsaka, Kenji Tatsuno, et al.
Case Reports in Oncological Medicine|April 8, 2020
Dual EGFR and ABL Tyrosine Kinase Inhibitor Treatment in a Patient with Concomitant EGFR-Mutated Lung Adenocarcinoma and BCR-ABL1-Positive CMLKousuke Watanabe, Hidenori Kage, Saki Nagoshi, et al.
Practical Laboratory Medicine|February 26, 2024
Analysis of quality metrics in comprehensive cancer genomic profiling using a dual DNA-RNA panelKousuke Watanabe, Shinji Kohsaka, Kenji Tatsuno, et al.
Biochemical and Biophysical Research Communications|January 18, 2015
Oncogenic TPM3-ALK activation requires dimerization through the coiled-coil structure of TPM3Yosuke Amano, Rie Ishikawa, Toshio Sakatani, et al.
Cancer Science|August 13, 2013
Detection of novel paraja ring finger 2-fer tyrosine kinase mRNA chimeras is associated with poor postoperative prognosis in non-small cell lung cancerMasanori Kawakami, Rie Ishikawa, Yosuke Amano, et al.
Respiratory Investigation|April 28, 2024
NECTIN2 is a prognostic biomarker and potential therapeutic target in lung adenocarcinomaTakahiro Ando, Mirei Ka, Yuriko Sugiura, et al.
Circulation Reports|December 11, 2025
Risk Factors and Prognostic Significance of Non-Perioperative Atrial Fibrillation in Lung Cancer PatientsTsukasa Oshima, Hiroshi Akazawa, Junichi Ishida, et al.
Japanese Journal of Clinical Oncology|March 24, 2017
High expression of IRE1 in lung adenocarcinoma is associated with a lower rate of recurrenceToshio Sakatani, Keita Maemura, Noriko Hiyama, et al.
Cancer Science|November 29, 2019
Integrin α11 in non-small cell lung cancer is associated with tumor progression and postoperative recurrenceTakahiro Ando, Hidenori Kage, Yoko Matsumoto, et al.
Cancer Science|July 20, 2018
Altered editing level of microRNAs is a potential biomarker in lung adenocarcinomaKeita Maemura, Kousuke Watanabe, Takahiro Ando, et al.
Pageof 6